G. Harcourt

发表

Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen-specific CD4+T cells in peripheral blood mononuclear cells.

P. Klenerman, A. McMichael, A. Kelleher, 2002, European journal of immunology.

Virological footprint of CD 4 + T-cell responses during chronic hepatitis C virus infection

P. Klenerman, E. Barnes, G. Harcourt, 2010 .

Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection

P. Klenerman, E. Barnes, G. Harcourt, 2010, The Journal of general virology.

Evidence for lack of cross‐genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection

P. Klenerman, M. Lucas, A. Godkin, 2003, Clinical and experimental immunology.

Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.

J. Best, J. Banatvala, G. Harcourt, 1980, The Journal of infectious diseases.

CD4+ T cells: The great escape

R. Phillips, G. Harcourt, D. Price, 2001, Nature Medicine.

Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells

N. Gilhus, A. Vincent, D. Beeson, 1995, Journal of Neuroimmunology.

HCV-indeterminate blood donors or occult HCV infection?

P. Klenerman, G. Harcourt, N. Semmo, 2005, The Lancet.

Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen‐specific CD4+T cells in peripheral blood mononuclear cells

P. Klenerman, A. McMichael, A. Kelleher, 2002 .

Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection

P. Klenerman, V. Cerundolo, M. Lucas, 2003, Journal of Virology.

HLA antigens and responses to rubella vaccination

J. Best, J. Banatvala, G. Harcourt, 1979, Journal of Hygiene.

T Cell Reactivity to Acetylcholine Receptor in Myasthenia Gravis

A. Vincent, J. Newsom-Davis, N. Willcox, 1990 .

T-cell reactivity in myasthenia gravis.

J. Rothbard, J. Newsom-Davis, N. Willcox, 1989, Journal of autoimmunity.

A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.

J. Rothbard, J. Newsom-Davis, G. Harcourt, 1988, The Journal of clinical investigation.

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy

P. Klenerman, A. Telenti, H. Günthard, 2010, Gut.

T cell responses to human recombinant acetylcholine receptor‐α subunitin myasthenia gravis and controls

T. Olsson, Zeng-Yu Wang, H. Link, 1992, European journal of immunology.

RUBELLA VACCINES

J. Best, S. O'shea, G. Harcourt, 1979, The Lancet.

Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection

P. Klenerman, M. Lucas, G. Harcourt, 2005, Hepatology.

Immunology of viral co-infections with HIV.

P. Klenerman, M. Lucas, G. Harcourt, 2005, Archivum immunologiae et therapiae experimentalis.

Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA‐DR11 restricted epitopes

P. Klenerman, E. Barnes, M. Lucas, 2004, Journal of viral hepatitis.

The dynamics of T‐lymphocyte responses during combination therapy for chronic hepatitis C virus infection

P. Klenerman, R. Phillips, E. Barnes, 2002, Hepatology.

Diminished frequency of hepatitis C virus specific interferon γ secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients

P. Klenerman, S. Donfield, E. Gomperts, 2006, Gut.

Immunity to hepatitis C virus: stunned but not defeated.

P. Klenerman, E. Barnes, M. Lucas, 2002, Microbes and infection.

Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

B. Walker, P. Klenerman, G. Lauer, 2003, The Journal of clinical investigation.

Identification of key peptide‐specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations

P. Klenerman, T. Scriba, G. Harcourt, 2006, Clinical and experimental immunology.

T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors

P. Klenerman, E. Barnes, J. Kurtz, 2005, The Lancet.

HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition

Miles P. Davenport, R. Phillips, M. Davenport, 1998, The Journal of experimental medicine.

Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection

J. Satsangi, P. Klenerman, R. Chapman, 2001, Journal of viral hepatitis.

Immunological Heterogeneity and Cellular Mechanisms in Myasthenia Gravis a

M. Schluep, A. Vincent, S. Mossman, 1987, Annals of the New York Academy of Sciences.

Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.

P. Klenerman, E. Barnes, M. Lucas, 2003, Immunology letters.

Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides

R. Phillips, P. Goulder, A. Sewell, 1997, European journal of immunology.

Blood and thymic lymphocyte responses to peptide sequences of the acetylcholine receptor in myasthenia gravis

J. Rothbard, J. Newsom-Davis, N. Willcox, 1987, Journal of Neuroimmunology.

British Association for the Study of the Liver

A. Perelson, C. Dejong, Y. Ma, 1991 .

Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs

P. Klenerman, R. Phillips, E. Daar, 2005, AIDS.

Rubella immunity by four different techniques: results of challenge studies

J. Best, J. Banatvala, S. O'shea, 1980, Journal of medical virology.

RUBELLA-IMMUNITY GAP: IS INTRANASAL VACCINATION THE ANSWER?

J. Best, G. Harcourt, J. Banatvala, 1979, The Lancet.

Cellular and humoral immunity in patients with insulin-dependent diabetes

J. Newsom-Davis, N. Pantic, N. Willcox, 1993, The Lancet.

Mapping the autoimmunizing epitopes on acetylcholine receptors.

A. Jermy, G. Harcourt, 1987, Immunology today.

HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition

M. Davenport, A. Edwards, G. Harcourt, 1998, The Journal of experimental medicine.